Janice M. Mehnert

Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study

Nicole M. Kuderer, Toni K. Choueiri, Dimpy P. Shah et al. · The Lancet · 2020 · 1.8K citations · Full text

Medicine, Clinical Sciences, Oncology +8

Pembrolizumab in Patients With Extensive-Stage Small-Cell Lung Cancer: Results From the Phase Ib KEYNOTE-028 Study

Patrick A. Ott, Elena Élez, Sandrine Hiret et al. · Journal of Clinical Oncology · 2017 · 538 citations

Medicine, Oncology, Pharmacotherapy +17

Pembrolizumab After Two or More Lines of Previous Therapy in Patients With Recurrent or Metastatic SCLC: Results From the KEYNOTE-028 and KEYNOTE-158 Studies

Hyun Cheol Chung, Sarina A. Piha‐Paul, José A. López-Martín et al. · Journal of Thoracic Oncology · 2019 · 438 citations · Full text

Medicine, Oncology, Pharmacotherapy +12

Safety and antitumor activity of the anti–PD-1 antibody pembrolizumab in patients with advanced, PD-L1–positive papillary or follicular thyroid cancer

Janice M. Mehnert, Andréa Varga, Marcia S. Brose et al. · BMC Cancer · 2019 · 221 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +17

<i>Atg7</i> Overcomes Senescence and Promotes Growth of <i>Braf</i> V600E-Driven Melanoma

Xiaoqi Xie, Ju Yong Koh, Sandy M. Price et al. · Cancer Discovery · 2015 · 216 citations · Full text

Life Sciences, Cancer Biology, Oncology +17